OOIR: Observatory of International Research

Papers

(The TQCC of Scandinavian Journal of Rheumatology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: results of a pilot study	53
Orbital and periorbital inflammation in VEXAS syndrome	20
Pamidronate in chronic non-bacterial osteomyelitis: a randomized, double-blinded, placebo-controlled pilot trial	19
Large-vessel giant cell arteritis after COVID-19 vaccine	19
Elevated adiponectin predicts the development of rheumatoid arthritis in subjects with obesity	17
Efficacy and safety of iguratimod on patients with primary Sjögren’s syndrome: a randomized, placebo-controlled clinical trial	16
Temporomandibular joint involvement in patients with juvenile idiopathic arthritis: a retrospective chart review	14
The validity of rheumatoid arthritis diagnoses in Finnish biobanks	13
Association between inflammasome-related polymorphisms and psoriatic arthritis	13
Presenting features and outcomes of cranial-limited and large-vessel giant cell arteritis: a retrospective cohort study	12
Lessons learned from clinical phenotypes in early psoriatic arthritis: the real-world Dutch south west Early Psoriatic ARthritis study	12
Pneumococcal antibody protection in patients with autoimmune inflammatory rheumatic diseases with varying vaccination status	12
Anti-cyclic citrullinated peptide antibodies are associated with radiographic damage but not disease activity in early rheumatoid arthritis diagnosed in 2006–2011	12
Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients	12
Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain	12
SLCO1B1 variants as predictors of methotrexate-related toxicity in children with juvenile idiopathic arthritis	11
Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents	11
Systemic Capillary Leak Syndrome triggered by SARS-CoV2 infection: Case Report and Systematic Review	11
Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases	10
Feasibility and estimated efficacy of blood flow restricted training in female patients with rheumatoid arthritis: a randomized controlled pilot study	9
Incidence and prevalence of rheumatoid arthritis in Denmark from 1998 to 2018: a nationwide register-based study	9
Do magnetic resonance imaging-detected erosions predict progression to rheumatoid arthritis in patients presenting with clinically suspect arthralgia? A longitudinal study	9
Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis:A randomized, crossover, agreement study	9
Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register	8
Lupus hepatitis, more than just elevated liver enzymes	8

Tapering of Etanercept is feasible in patients with Rheumatoid Arthritis in sustained remission: a pragmatic randomized controlled trial	8
Temperature response to cold challenge and mobile phone thermography as outcome measures for systemic sclerosis-related Raynaud’s phenomenon	8
Pretreatment resistin levels are associated with erosive disease in early rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs and infliximab	8
Twenty-year changes in mortality rates and underlying causes of death in patients with rheumatoid arthritis-associated interstitial lung disease	8
Reduction of Pneumocystis jirovecii pneumonia and bloodstream infections by trimethoprim–sulfamethoxazole prophylaxis in patients with rheumatic diseases	8
Tocilizumab and rituximab for anti-MDA-5 positive amyopathic dermatomyositis complicated with macrophage activation syndrome and progressive fibrosing interstitial lung disease	8
Association of weather factors with the risk of pain exacerbations in people with hip osteoarthritis	7
Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial	7
Self-limiting reactive disease mimicking polymyalgia rheumatica following Moderna COVID-19 vaccine	7
Rheumatological evaluation of patients with interstitial lung disease	7
Cost-effectiveness of a telehealth intervention in rheumatoid arthritis: economic evaluation of the Telehealth in RA (TeRA) randomized controlled trial	7
Pneumocystis jirovecii pneumonia in patients treated for systemic autoimmune disorders: a retrospective analysis of patient characteristics and outcome	7
Early radiological progression remains associated with long-term joint damage in real-world rheumatoid arthritis patients treated to the target of remission	7
Extended-release tofacitinib improves refractory Takayasu’s arteritis	7
Reproductive history and osteoarthritis in the Women’s Health Initiative	7
Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis	7
Lifestyle factors and comorbidities in gout patients compared to the general population in Western Sweden: results from a questionnaire study	7
Serum levels of n-3 and n-6 polyunsaturated fatty acids in patients with systemic lupus erythematosus and their association with disease activity: a pilot study	7
Diffuse idiopathic skeletal hyperostosis in elderly Icelanders and its association with the metabolic syndrome: the AGES-Reykjavik Study	7
The changing incidence of rheumatoid arthritis over time in north-west Greece: data from a referral centre	7
Major reduction of ultrasound-detected synovitis during subcutaneous tocilizumab treatment: results from a multicentre 24 week study of patients with rheumatoid arthritis	6
Detection of human cytomegalovirus in synovial neutrophils obtained from patients with rheumatoid arthritis	6
Adenosine receptor A2a blockade by caffeine increases IFN–gamma production in Th1 cells from patients with rheumatoid arthritis	6
Complications after minor salivary gland biopsy: a retrospective study of 630 patients from two Swedish centres	6
Pentraxin-3 – a potential biomarker in ANCA-associated vasculitis	6
Muscle wasting, a neglected complication associated with physical dysfunction in elderly patients with rheumatoid arthritis: a cross-sectional observational study	6
Nailfold videocapillaroscopy: a novel possible surrogate marker for the evaluation of peripheral microangiopathy in pulmonary arterial hypertension	6
Rheumatoid arthritis and the risk of major cardiometabolic diseases: a Mendelian randomization study	6
Widespread non-joint pain in early rheumatoid arthritis	6
Clinical phenotypes of Behçet’s syndrome in a large cohort of Italian patients: focus on gender differences	6
Extent of atherosclerosis after 11-year prospective follow-up in patients with early rheumatoid arthritis was affected by disease severity at diagnosis	6
Low body weight and involuntary weight loss are associated with Raynaud’s phenomenon in both men and women	6
Incidence and predictors of thoracic aortic damage in biopsy-proven giant cell arteritis	6
Effects of cigarette smoking and human T-cell leukaemia virus type 1 infection on anti-citrullinated peptide antibody production in Japanese community-dwelling adults: the Nagasaki Islands Study	6
Urgent manifestations of immunoglobulin G₄-related disease	6
Pregnancy outcome in women with different rheumatic diseases: a retrospective analysis	6
Increased prevalence of sleep disturbance in psoriatic arthritis is associated with inflammatory and non-inflammatory measures	6
The feasible maintenance dose of corticosteroid in Takayasu arteritis in the era of biologic therapy	6
Sirolimus use in patients with subglottic stenosis in the context of granulomatosis with polyangiitis (GPA), suspected GPA, and immunoglobulin G₄-related disease	6
Risk of cancer in patients with ankylosing spondylitis: a nationwide cohort study in Taiwan	6
Prostanoids in scleroderma microangiopathy: clinical and pharmacoeconomic comparison between two intravenous regimens	6
Prognostic value of peripheral blood markers in patients with myositis-associated interstitial lung diseases	6
Disease activity in women with ankylosing spondylitis remains higher under Tumour Necrosis Factor inhibitor treatment than in men: a five-year observational study	6
Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis	6
Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients	6
Complement activation prior to symptom onset in myeloperoxidase ANCA-associated vasculitis but not proteinase 3 ANCA associated vasculitis - A Swedish biobank study	6
Disease activity trajectories in rheumatoid arthritis: a tool for prediction of outcome	5
Fluorescence optical imaging in patients with active rheumatoid arthritis: a comparison with ultrasound and an association with biomarkers	5
Arthropathy in hereditary haemochromatosis segregates with elevated erythrocyte mean corpuscular volume	5
Associations of serum monocyte-to-high-density lipoprotein cholesterol ratio with digital ulcers and skin fibrosis in patients with systemic sclerosis	5

Diagnosing axial spondyloarthritis by multidiciplinary team conference at 3.5 years’ follow-up in a cohort of patients with disease features according to the ASAS criteria	5
Prevalence of survey-based criteria for fibromyalgia and impact on hospital burden: a 7 year follow-up study from an outpatient clinic	5
Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study	5
Risk of Staphylococcus aureus bacteraemia in patients with rheumatoid arthritis and the effect of orthopaedic implants on the risk: a nationwide observational cohort study	5
Detectable anti-proteinase-3 antibodies precede clinical manifestations in a case of anti-neutrophil cytoplasmic antibody-associated vasculitis	5
Resilience of systemic sclerosis patients following the first COVID-19 wave in Italy	5
Reduced prescription of TNF-inhibitors in chronic arthritis based on therapeutic drug monitoring: A randomized controlled trial	4
Patient characteristics in Behçet’s Syndrome and their associations with major organ involvement: a single-centre experience of 2118 cases	4
Transition to adult care in Finnish adolescents with juvenile idiopathic arthritis	4
The Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: predicting clinical arthritis development	4
Smoking associated with reduced odds of Sjögren’s syndrome among rheumatoid arthritis patients	4
Gout in Dalarna, Sweden – a population-based study of gout occurrence and compliance to treatment guidelines	4
Relationship between sex and clinical and imaging features of early axial spondyloarthritis: results from a 48 month follow-up (Italian arm of the SPondyloArthritis Caught Early (SPACE) study)	4
A case of myositis with dropped head syndrome and anti-titin antibody positivity induced by pembrolizumab	4
Serum CCL28 as a biomarker for diagnosis and evaluation of Sjögren’s syndrome	4
Successful treatment with cyclosporine and anti-tumour necrosis factor agent for deficiency of adenosine deaminase-2	4
Corticosteroids reduce vascular ultrasound sensitivity in fast- track pathways (FTP): results from Coventry Multi-Disciplinary FTP for cranial Giant Cell Arteritis	4
Rheumatoid cachexia in early rheumatoid arthritis: prevalence and associated variables	4
Natural disease progression in finger osteoarthritis: results from a 10 year follow-up cohort	4
Validity and reliability of the Swedish version of the Self-Efficacy for Managing Chronic Disease scale for individuals with systemic sclerosis	4
Increased risk of end-stage renal disease in patients with systemic sclerosis	4
Worse scores but similar patterns of disease activity: interpreting outcomes in women with axial spondyloarthropathy	4
Successful treatment of Cogan’s syndrome with tocilizumab	4
Favorable clinical response and drug retention of anti-IL-6 receptor inhibitor in rheumatoid arthritis with high CRP levels: the ANSWER cohort study	4
Evaluation of risk factors and biomarkers related to arterial and venous thrombotic events in idiopathic inflammatory myopathies	4
Relationship between faecal calprotectin and inflammation in peripheral joints and entheses in axial spondyloarthritis	4
Refractory mixed proliferative and membranous lupus nephritis treated with the topoisomerase I inhibitor irinotecan as add-on therapy	4
Behcet’s-like disease in a patient treated with Ixekizumab for chronic plaque psoriasis	4
Role of comorbidities on therapeutic persistence of biological agents in rheumatoid arthritis: results from the RECord-linkage On Rheumatic Disease study on administrative healthcare databases	4
Unacceptable pain in the BARFOT inception cohort of patients with rheumatoid arthritis: a long-term study	4
Cluster analysis identifies unmet healthcare needs among patients with rheumatoid arthritis	4
Can pain flares in knee osteoarthritis be predicted?	4